Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
MoonLake Immunotherapeutics (MLTX) Insider Trading Activity
Healthcare • Biotechnology • 50 employees
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Total Value
-$109,189,320.00
Total Shares
-2,171,000
Average Trade Value
-$27,297,330.00
Most Active Insider
Bvf Partners L P/Il
Total Activity: $100,003,200
Largest Single Transaction
$51,531,099
by Bvf Partners L P/Il on Oct 4, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Director, 10% Owner
|
Oct 4, 2024 | 1,030,589 | $51,531,099 | 10,235,089 (-10.1%) | Sale | |
Director, 10% Owner
|
Oct 4, 2024 | 132,549 | $6,627,662 | 1,287,768 (-10.3%) | Sale | |
Director, 10% Owner
|
Oct 4, 2024 | 836,862 | $41,844,439 | 8,168,838 (-10.2%) | Sale | |
Director
|
Oct 4, 2024 | 171,000 | $9,186,120 | 171,980 (-99.4%) | Sale |